Icept Tablet 23 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
IntroBioPharma Co., Ltd.
MFDS item code 202104019 · Approved 2021.05.21
Treatment of symptoms of moderate to severe Alzheimer-type dementia
This medication is used for the treatment of moderate to severe symptoms of Alzheimer's dementia. It helps improve various symptoms caused by dementia, such as memory impairment and cognitive dysfunction, assisting in enhancing the patient's daily functional capabilities.
Take this medicine once daily in the evening immediately before bedtime. It may be taken with or without food. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Do not split, crush, or chew this medicine, as this may increase the rate of absorption. The recommended initial dose of donepezil hydrochloride is 5mg once daily. This medicine reaches steady state 15 days after administration, and the incidence of adverse reactions may be affected by the rate of dose escalation; therefore, administer 5mg for 4 ~ 6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10mg. When increasing the dose to 10mg daily, administer with caution for gastrointestinal adverse reactions. Patients who have taken 10mg once daily for at least 3 months may be given 23mg once daily.
This medication is primarily composed of donepezil hydrochloride and is used to alleviate the symptoms of Alzheimer's dementia. This medication should not be administered to specific patients. For instance, patients who are allergic to this medication or its ingredients, women who are pregnant or may become pregnant, and women who are breastfeeding should not use this medication. Additionally, patients with lactose intolerance or genetic lactose-related disorders should not take this medication. Patients with heart diseases or arrhythmia, those with a history of peptic ulcers or currently taking non-steroidal anti-inflammatory drugs, patients with asthma or a history of obstructive pulmonary disease, patients with extrapyramidal disorders such as Parkinson's disease, and those allergic to yellow No. 4 (tartrazine) contained in this medication should use this medication with caution. During the use of this medication, various adverse reactions may occur, and in severe cases, immediate consultation with a doctor is advised. Common adverse reactions include fainting, arrhythmias, exacerbation of peptic ulcers, liver dysfunction, cerebrovascular issues, motor function disorders, muscle abnormalities, respiratory distress, acute pancreatitis, and acute renal failure. Furthermore, various side effects such as nausea, vomiting, diarrhea, dizziness, insomnia, hallucinations, depression, myalgia, skin rashes, and other issues have been reported. This medication is not approved for other forms of memory disorders aside from dementia and treatment should be conducted under the supervision of an experienced physician. Additionally, this medication may increase the risk of cardiac arrhythmias, thus patients with heart disease may require regular electrocardiograms. Since this medication is primarily metabolized in the liver, patients with impaired liver function require close monitoring, and drug interactions may affect efficacy; thus, it is essential to inform the doctor of any other medications being taken. Women who are pregnant or breastfeeding are advised not to use this medication unless it is absolutely necessary and decided cautiously by a specialist. Safety for pediatric use has not been established, so it is not to be used in children. In case of overdose, serious symptoms such as nausea, vomiting, bradycardia, hypotension, respiratory depression, and muscle weakness may occur, requiring immediate medical attention, and atropine may be used as an antidote. This medication should be stored in a tightly sealed container away from children's reach and transferring it to another container should be avoided to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, at a temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness.
Red, double-sided convex round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
IntroBioPharma Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.